Stelara (ustekinumab) - J&J
Entyvio (vedolizumab) - Takeda
A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease (clinicaltrials.gov) - Oct 16, 2026 - P=N/A | N=0 | Withdrawn | Sponsor: Takeda | N=23900 ➔ 0 | Not yet recruiting ➔ Withdrawn 
Enrollment change • Trial withdrawal • Crohn's disease • Gastroenterology • Gastrointestinal Disorder • Immunology • Infectious Disease • Inflammatory Bowel Disease • Ulcerative Colitis
http://clinicaltrials.gov/ct2/show/NCT07250815
 
Oct 16, 2026
 
Prev Next